GERMANY UP CLOSE: IVD Industry Says EU Regulatory Reform Must Be Proportionate And Relevant
This article was originally published in SRA
Germany's IVDs industry is the largest in Europe, with a local market valued at €2.2bn (reagents and equipment/systems) in 2014-15. It accounts for 20% of the wider European market, but the overwhelmingly SMEs-based industry is nervous about the changes that the proposed EU IVD Regulation will bring, clearly worried that an inappropriately heavy regulatory hand will damage the sector’s ability to innovate. Ashley Yeo reports.
You may also be interested in...
Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”
The EU Partnership on Health Innovation, a new public private health care research partnership, is in the final drafting phase before its launch under Horizon Europe. In Vivo asked the partnership’s medtech industry lead, Patrick Boisseau, to set out the innovation challenges for participants as they address unmet health care needs in Europe.
Chinese monitoring of the spread of COVID-19 locally has reported no new cases of home-grown infection in a single day for the first time since the outbreak began. It indicates control efforts, including the NMPA’s fast-tracking of relevant devices, PPE and IVDs, are having the desired effects.